Thursday, 23 January 2020
  • Contact Us

Spaulding Clinical Logo

  • Home
  • About
    • Message From CEO
    • Video Tour
    • Our Approach
    • Expertise
    • People
    • Partners
    • Community
    • Facility
    • Directions
  • Clinical Research
    • Clinical Pharmacology
      • Study Capabilities
      • High Visibility Unit
      • Study Metrics
      • Phase I EDC Solution
      • Recruitment
      • Study Environment
      • Case Studies
    • Biometrics
      • Spaulding Clinical Data Advantage
      • Services
      • Quick Facts
      • Case Studies
    • Cardiac Safety Solutions
      • Spaulding Cardiac Advantage
      • Capabilities
      • Spaulding Electrocardiograph Workflow
      • Sponsor Feedback
    • Case Studies
  • ECG Solution
    • Spaulding Electrocardiograph
      • Spaulding Electrocardiograph Demo
      • Quick Facts
      • Specifications
      • Sample Report
  • Careers
    • Structure
      • Job Postings
      • Who We Are
      • What We Offer
    • Apply Now
  • Resources
    • Type
      • Publications
      • Webinars
      • Podcasts
      • Videos
  • Volunteer
    • Available Studies
    • Study Environment
    • Frequently Asked Questions
    • Referral Program
    • Register for Volunteer Database
    • Travel / Hotel Information
  • News
    • Latest News
    • Upcoming Events

podcasts

Spaulding Clinical Podcast Design Cover

The Spaulding Clinical Research Podcast  |  25 April 2017

Which Protocol Should I Use: The Standard ICH E14 Thorough QT/QTc Study or Concentration-effect Modelling?

Today's podcast comes from Dan Selness, Chief Strategy Officer of Spaulding Clinical Research and Dr. Jay Mason, a Professor of Medicine (Cardiology) at the University of Utah, Chief Medical Officer at Spaulding Clinical Research, and an independent consultant in cardiac safety. Listen Now

CEM vs TQT Summary PDF Slides

© 2012 - 2016 Spaulding Clinical Research. All rights reserved. | Privacy Policy